Deferred Income Tax Liabilities, Net in USD of Barinthus Biotherapeutics plc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Barinthus Biotherapeutics plc. quarterly Deferred Income Tax Liabilities, Net history and change rate from Q4 2020 to Q3 2025.
  • Barinthus Biotherapeutics plc. Deferred Income Tax Liabilities, Net for the quarter ending 30 Sep 2025 was $320K, a 30% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

Barinthus Biotherapeutics plc. Quarterly Deferred Income Tax Liabilities, Net (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $320K -$137K -30% 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 $391K 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $416K 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $438K -$136K -23.7% 31 Dec 2024 10-Q 07 Nov 2025
Q3 2024 $457K 30 Sep 2024 10-Q 06 Nov 2024
Q4 2023 $574K -$12.1M -95.5% 31 Dec 2023 10-K 20 Mar 2025
Q4 2022 $12.7M +$593K +4.91% 31 Dec 2022 10-K 20 Mar 2024
Q4 2021 $12.1M +$10.5M +664% 31 Dec 2021 10-K 24 Mar 2023
Q4 2020 $1.58M 31 Dec 2020 10-K 25 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.